Clinical Trial Update: Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase II trial evaluating interleukin-2 with priming and GM-CSF in advanced malignant melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Mt. Sinai Medical Center, Miami | Conditions: Malignant Melanoma | Phase 2 | Status: COMPLETED